| Description | Eftilagimod alfa (IMP321), a recombinant LAG-3Ig fusion protein, binds to MHC class II and mediates the activation of antigen-presenting cells (APCs), which in turn activates CD8 T-cells. It is utilized in the research of metastatic melanoma and metastatic breast carcinoma [1]. |
| Synonyms | IMP321, LAG-3Ig |
| molecular weight | N/A |
| CAS | 1800476-36-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |